Analysis of epistasis for diabetic nephropathy among type 2 diabetic patients

被引:21
作者
Hsieh, Chang-Hsun
Liang, Kung-Hao
Hung, Yi-Jen
Huang, Li-Chin
Pei, Dee
Liao, Ya-Tang
Kuo, Shi-Wen
Bey, Monica Shian-Jy
Chen, Jui-Lin
Chen, Ellson Y.
机构
[1] Vita Genom Inc, Taipei 248, Taiwan
[2] Tri Serv Gen Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei, Taiwan
[3] Xindian Buddhist Tzu Chi Hosp, Dept Internal Med, Taipei, Taiwan
关键词
D O I
10.1093/hmg/ddl203
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diabetic nephropathy (DN) is one of the most serious complications of diabetes, accounting for the majority of patients with end-stage renal disease. The molecular pathogenesis of DN involves multiple pathways in a complex, partially resolved manner. The paper presents an exploratory epistatic study for DN. Association analysis were performed on 231 SNP loci in a cohort of 264 type 2 diabetes patients, followed by the epistasis analysis using the multifactor dimensionality reduction and the genetic algorithm with Boolean algebra. A two-locus epistatic effect of EGFR and RXRG was identified, with a cross-validation consistency of 91.7%.
引用
收藏
页码:2701 / 2708
页数:8
相关论文
共 50 条
  • [21] Maternal history of type 2 diabetes is associated with diabetic nephropathy in type 1 diabetic patients
    Hadjadj, S.
    Duengler, F.
    Torremocha, F.
    Faure-Gerard, G.
    Bridoux, F.
    Boissonnot, M.
    Mauco, G.
    Guilhot, J.
    Marechaud, R.
    DIABETES & METABOLISM, 2007, 33 (01) : 37 - 43
  • [22] MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients
    Maeda, Makiko
    Yamamoto, Isamu
    Fukuda, Masakatsu
    Motomura, Takashi
    Nishida, Mari
    Nonen, Shinpei
    Kasayama, Soji
    Fujio, Yasushi
    Azuma, Junichi
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2008, 22 (02) : 119 - 125
  • [23] Progression of diabetic nephropathy in normotensive type 1 diabetic patients
    Jacobsen, P
    Rossing, K
    Tarnow, L
    Rossing, P
    Mallet, C
    Poirier, O
    Cambien, F
    Parving, HH
    KIDNEY INTERNATIONAL, 1999, 56 : S101 - S105
  • [24] Analysis of QTc interval in type-2 diabetic patients with overt nephropathy
    Giménez-Pérez, G
    Arroyo, JA
    López, T
    Ponz, E
    Mauricio, D
    DIABETOLOGIA, 1999, 42 : A296 - A296
  • [25] Analysis of risk factors for progression of diabetic nephropathy in patients with type 2 diabetes
    Kovacevic, Marijana
    Kovacevic, Maksim
    Prodanovic, Verica
    Cancar, Olivera
    Malis, Snezana
    Cancar, Vladimir
    Dukanovic, Ljubica
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2021, 149 (5-6) : 295 - 300
  • [26] Soy Milk Consumption and Blood Pressure Among Type 2 Diabetic Patients With Nephropathy
    Miraghajani, Maryam Sadat
    Najafabadi, Mojgan Mortazavi
    Surkan, Pamela J.
    Esmaillzadeh, Ahmad
    Mirlohi, Maryam
    Azadbakht, Leila
    JOURNAL OF RENAL NUTRITION, 2013, 23 (04) : 277 - U43
  • [27] Evaluation of serum levels of sestrin 2 and betatrophin in type 2 diabetic patients with diabetic nephropathy
    Emara, Asmaa Mounir
    El Bendary, Amal Said
    Ahmed, Laila Mahmoud
    Okda, Hanaa Ibrahim
    BMC NEPHROLOGY, 2024, 25 (01)
  • [28] Progression of diabetic nephropathy enhances the plasma osteopontin level in type 2 diabetic patients
    Yamaguchi, H
    Igarashi, M
    Hirata, A
    Tsuchiya, H
    Sugiyama, K
    Morita, Y
    Jimbu, Y
    Ohnuma, H
    Daimon, M
    Tominaga, M
    Kato, T
    ENDOCRINE JOURNAL, 2004, 51 (05) : 499 - 504
  • [29] Diabetic retinopathy in predicting diabetic nephropathy in patients with type 2 diabetes and renal disease: a meta-analysis
    F. He
    X. Xia
    X. F. Wu
    X. Q. Yu
    F. X. Huang
    Diabetologia, 2013, 56 : 457 - 466
  • [30] PROTEINURIA IN TYPE 2 DIABETIC PATIENTS WITH RENAL IMPAIRMENT: THE CHANGING FACE OF DIABETIC NEPHROPATHY
    Packham, D.
    Ivory, S.
    Reutens, A.
    Wolfe, R.
    Rohde, R.
    Heerspink, H.
    Dwyer, J.
    Atkins, R.
    Lewis, J.
    NEPHROLOGY, 2010, 15 : 32 - 32